Cite
APA Citation
Tritz, Z., Ayasoufi, K., Malo, C., Himes, B., Khadka, R., Fain, C., Goddery, E., Yokanovich, L., Jin, F., Hansen, M., Parney, I., Wang, C., Moynihan, K., Irvine, D., Wittrup, D., & Johnson, A. (2021). eXTH-66. ENHANCEMENT OF ANTI-PD-1 THERAPY WITH EXTENDED HALF-LIFE IL-2 IS INDEPENDENT OF MHC CLASS I RESTRICTED ANTIGEN RECOGNITION FOR TREATMENT OF EXPERIMENTAL GLIOMA. Neuro-oncology, 23, vi178. http://access.bl.uk/ark:/81055/vdc_100146089938.0x000012